| The role of alpha-synuclein and other Parkinson’s genes in neurodevelopmental and neurodegenerative disorders CA Morato Torres, Z Wassouf, F Zafar, D Sastre, TF Outeiro, B Schüle International journal of molecular sciences 21 (16), 5724, 2020 | 51 | 2020 |
| ATTCT and ATTCC repeat expansions in the ATXN10 gene affect disease penetrance of spinocerebellar ataxia type 10 CAM Torres, F Zafar, YC Tsai, JP Vazquez, MD Gallagher, I McLaughlin, ... Human Genetics and Genomics Advances 3 (4), 2022 | 17 | 2022 |
| Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson’s disease F Zafar, VN Srinivasaraghavan, MY Chen, CAM Torres, B Schüle Stem Cell Research 60, 102733, 2022 | 7 | 2022 |
| Early embryonic lethality in complex I associated p.L104PNubpl mutant mice C Cheng, J Cleak, L Weiss, H Cater, M Stewart, S Wells, RC Columbres, ... Orphanet journal of rare diseases 17 (1), 386, 2022 | 5 | 2022 |
| Multiplex imaging of human induced pluripotent stem cell-derived neurons with CO-Detection by indEXing (CODEX) technology L Heinrich, F Zafar, CAM Torres, J Singh, A Khan, MY Chen, C Hempel, ... Journal of Neuroscience Methods 378, 109653, 2022 | 5 | 2022 |
| Embryoid body formation from mouse and human pluripotent stem cells for transplantation to study brain microenvironment and cellular differentiation M Guerra-Crespo, O Collazo-Navarrete, R Ramos-Acevedo, ... Embryonic Stem Cell Protocols, 215-232, 2021 | 3 | 2021 |
| Inactive S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in human stem cell model of Parkinson’s disease D Sastre, F Zafar, CAM Torres, D Piper, D Kirik, LH Sanders, LS Qi, ... Scientific Reports 13 (1), 17796, 2023 | 2 | 2023 |
| Embryoid Body Cells from Human Embryonic Stem Cells Overexpressing Dopaminergic Transcription Factors Survive and Initiate Neurogenesis via Neural Rosettes in the Substantia Nigra R Ramos-Acevedo, CA Morato-Torres, FJ Padilla-Godínez, ... Brain Sciences 13 (2), 329, 2023 | 2 | 2023 |
| Nuclease-dead S. aureus Cas9 downregulates alpha-synuclein and reduces mtDNA damage and oxidative stress levels in patient-derived stem cell model of Parkinson’s disease D Sastre, F Zafar, CAM Torres, D Piper, D Kirik, LH Sanders, S Qi, ... bioRxiv, 2023 | 2 | 2023 |
| Alpha-Synuclein Gene Alterations Modulate Tyrosine Hydroxylase in Human iPSC-Derived Neurons in a Parkinson’s Disease Animal Model LD Bernal-Conde, V Peña-Martínez, CA Morato-Torres, ... Life 14 (6), 728, 2024 | | 2024 |
| Robust nuclease-dead S. aureus dCas9-mediated alpha-synuclein knockdown in substantia nigra in a humanized mouse model of Parkinson's disease CAM Torres, F Zafar, D Sastre, DA Hermesky, MY Chen, JP Vazquez, ... bioRxiv, 2023.09. 05.556425, 2023 | | 2023 |
| Human embryonic stem cells overexpressing dopaminergic transcription factors survive and differentiate in the substantia nigra in vivo R Ramos-Acevedo, CA Morato-Torres, LD Bernal-Conde, ... | | 2022 |
